Results 221 to 230 of about 52,877 (267)
Some of the next articles are maybe not open access.

Ivermectin: An update

Parasitology Today, 1985
Ivermecan was introduced as an antiparasitic agent in 1981. It is now registered for animal-health use in 35 countries and is being evaluated for possible use in man. This review summarises its antiparasitic efficacy and apparent mode of action. Additional information is given in previous review articles.
openaire   +2 more sources

Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled Trial.

Clinical Infectious Diseases, 2021
BACKGROUND Dengue is the most significant mosquito-borne viral disease; there are no specific therapeutics. The antiparasitic drug ivermectin efficiently inhibits the replication of all 4 dengue virus serotypes in vitro.
Y. Suputtamongkol   +14 more
semanticscholar   +1 more source

Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study

British Journal of Dermatology, 2020
Scabies is a frequent condition seen in infants and children. Only topical treatments have been approved in infants, but some of them are poorly tolerated.
M. Levy   +7 more
semanticscholar   +1 more source

Ivermectin: a mini-review

Clinical toxicology, 2022
K. Johnson-Arbor
semanticscholar   +1 more source

Ivermectin

Reactions Weekly, 2021
openaire   +2 more sources

Ivermectin

Reactions Weekly, 1993
openaire   +2 more sources

Home - About - Disclaimer - Privacy